Concord Drugs Share Price
03 Sep, 2026 4:01 PM (IST)
Concord Drugs Performance
- Today's Low
- ₹79
- Today's High
- ₹84
- 52 Week Low
- ₹60
- 52 Week High
- ₹93
- Open Price₹84
- Previous Close₹79
- Volume2,781
- 50 DMA₹75.50
- 100 DMA₹75.80
- 200 DMA₹73.60
Concord Drugs Chart
Investment Returns
- Over 1 Month + 10.56%
- Over 3 Month + 2.12%
- Over 6 Month + 8.99%
- Over 1 Year + 30.9%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 52.5
- PEG Ratio
- 0.1
- Market Cap Cr
- 108
- P/B Ratio
- 2.2
- Average True Range
- 4.8
- EPS
- 1.6
- Dividend Yield
- 0
- MACD Signal
- 2.1
- RSI
- 59.66
- MFI
- 83.44
Latest Stock News Updates
Copy of News-paper publications for quarterly results ended 30th June 2026.
- BSE India
- 3 weeks 1 day ago
Board of Directors have approved stand alone and consolidated Un-audited financial results for 30th June 2026
- BSE India
- 3 weeks 3 days ago
Outcome of Board meeting
- BSE India
- 3 weeks 3 days ago
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹76.90
- 50 Day
- ₹75.50
- 100 Day
- ₹75.80
- 200 Day
- ₹73.60
Resistance and Support
- R3 88.20
- R2 86.00
- R1 83.20
- S1 78.20
- S2 76.00
- S3 73.20
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-10 | Quarterly Results | |
| 2026-05-27 | Audited Results | |
| 2026-02-14 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results |
About Concord Drugs
Concord Drugs is to manufacture licensed drugs based on the formulations approved. View More- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Popular Stocks
Concord Drugs FAQs
Concord Drugs share price is ₹81 As on 04 September, 2026 | 05:00
The Market Cap of Concord Drugs is ₹107.8 Cr As on 04 September, 2026 | 05:00
The P/E ratio of Concord Drugs is 52.5 As on 04 September, 2026 | 05:00
The PB ratio of Concord Drugs is 2.2 As on 04 September, 2026 | 05:00
The 52 week High & Low of Concord Drugs is ₹92.5/₹60 respectively As on 04 September, 2026 | 05:00
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.